APIs & Raw Materials

APIs & Raw Materials

BASF offers a large variety of chemical raw materials to meet the specific needs of your API production.

The world's largest portfolio of chemical raw materials for the pharmaceutical industry


BASF’s broad portfolio of products and services across the pharmaceutical value chain also includes a comprehensive portfolio of synthesis tools such as top quality building blocks, synthetic and protecting group reagents, solvents, high-purity iron salts an catalysts. Customers benefit from the availability at commercial scale of chiral amines, alcohols, epoxides and acids that are marketed under the ChiPros® trademark and prepared using BASF’s robust technology platforms. Inorganic specialities such as organozinc‑halide reagents, boranes and a wide range of specialty alcoholates complete BASF’s pharma offering. BASF's catalysts portfolio includes fine-chemical catalysts and a full loop of metals-management services. Overall BASF develops, produces and markets over 700 chemical raw materials to meet specific needs of API production.

Leading supplier of omega-3 and ibuprofen

2.0_Pronova Pure.jpg

BASF is the world leading manufacturer of active pharmaceutical ingredients (APIs) such as ibuprofen and omega-3 fatty acids. BASF has focussed on the production of a small selected active pharmaceutical ingredients. Our portfolio also includes APIs such as Polyethylene Glycol 3350 (Macrogol/PEG) and L-Menthol. With a strong international presence, BASF is a truly global partner that can also offer reliable local support. And thanks to our state-of-the-art production facilities located around the world, we can deliver the products you need – wherever and whenever you need them.

Extensive technology platform

Die neue Gas- und Dampfturbinen-Anlage der BASF am Standort Ludwigshafen ist Spitzenreiter in der industriellen Energieumwandlung. Sie schont Ressourcen und verringert zugleich die CO2-Emissionen um mehr als 500.000 Tonnen pro Jahr. Dies entspricht dem jährlichen CO2-Ausstoß einer Stadt mit 50.000 Einwohnern. Das Prinzip ist einfach: Die entstehende Abgaswärme wird zum Herstellen von Dampf genutzt,  der dann in den Produktionsbetrieben des Werkes für unterschiedlichste chemische Prozesse verwendet wird. So gelingt es der BASF den Standort Ludwigshafen nicht nur optimal, sondern auch klimafreundlich mit Energie zu versorgen.  Abdruck honorarfrei. Copyright by BASF.

BASF’s new combined heat and power (CHP) plant at its Ludwigshafen site is a top performer in industrial energy conversion. It conserves resources and at the same time reduces CO2 emissions by more than 500,000 metric tons per year. This is equivalent to the annual CO2 emissions of a town with 50,000 inhabitants. The principle is simple: the waste heat is used to produce steam, which is then used by the site’s production plants for a wide variety of chemical processes. This means BASF not only optimally supplies its Ludwigshafen site with energy but does so in a climate friendly way.  Print free of charge. Copyright by BASF.

BASF has one of the most extensive technology platforms for manufacturing specialties for the pharmaceutical industry. These include technologies for chiral as well as achiral intermediates. The technology portfolio spans the whole range from classical to modern technologies like phosgene chemistry and enantioselective biotransformations.

More information

Excipients for Drug Formulation

Equipped with an in-depth understanding of multiple industries, technologies and applications, we have the skills and resources to make drug manufacturing more efficient, robust, and cost-effective. Whether you want to make your medicine more effective, safer, or more patient-friendly, BASF has the solution you need. Find the right answers to your pharmaceutical formulation challenges.

Read more

Our Portfolio